Skip to search formSkip to main contentSkip to account menu

Pseudohypoaldosteronism, Type II

Known as: Syndrome, Gordon Hyperkalemia-Hypertension, GORDON HYPERKALEMIA-HYPERTENSION SYNDROME, Pseudohypoaldosteronisms, Type II 
Autosomal dominant syndrome of renal electrolyte transport dysfunctions. The clinical features include salt-sensitive hypertension, renal… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2017
Highly Cited
2017
The heterogeneity of traumatic brain injury (TBI) is considered one of the most significant barriers to finding effective… 
Highly Cited
2008
Highly Cited
2008
Amorphous engineered particle compositions of itraconazole (ITZ) and potential concentration enhancing polymers, cellulose… 
Highly Cited
2007
Highly Cited
2007
With-no-lysine (WNK) kinases are a novel family of protein kinases characterized by an atypical placement of the catalytic lysine… 
Highly Cited
2003
Highly Cited
2003
Pseudohypoaldosteronism type II (PHAII) is an autosomal dominant disorder of hyperkalemia and hypertension. Mutations in two… 
Highly Cited
2002
Highly Cited
2002
Mutations in WNK kinases cause pseudohypoaldosteronism type II (PHA II) and may represent a novel signaling pathway regulating… 
Highly Cited
1997
Highly Cited
1997
The phylogenetic diversity of a continental‐shelf picoplankton community was examined by analyzing 16S ribosomal RNA (rRNA) genes… 
Highly Cited
1990
Highly Cited
1990
This paper reports anomalous price behavior around repurchase tender offers. Buying shares before the expiration date of a… 
Highly Cited
1983